Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study
published in: Journal of Crohn's and Colitis
date of publication: 2019-09-01
Cites articles
There is nothing here
Article - wd:Q91771920